Osteotech, Inc. - Sales Analysis Snapshot

Business Description
This Report provides a comprehensive Sales & Margin summary analysis for Osteotech, Inc. Tabular results include up to a ten-year history on Sales, EBITDA (Earnings before Interest, Taxes, Depreciation and Amortization), Income before Extraordinary Items and number of Employees. Additional ratios are included for sales growth, earnings and income as a percent of sales and Sales per Employee.

Osteotech, Inc.. The Group's principal activities are processing of human bone and connective tissue technologies for transplants and developing, manufacturing, and marketing biologic, biomaterial and device systems for musculoskeletal surgery. It has four operating segments: Demineralized Bone Matrix (DBM), Traditional Tissue, Spinal Allograft, Client Services and Hybrid/Synthetics. The DBM Segment provides processing and marketing of 'Grafton' and private label 'Demineralized Bone Matrix.' The Tissue Segment provides processing of mineralized weight-bearing allograft bone tissue. Other business units provide marketing and distributing metal spinal implant products and processing, marketing and distributing bovine tissue products. Products and services are marketed primarily to the orthopaedic, spinal, neurological, oral/maxillofacial, dental and general surgery customers in the United States, Europe and Asia.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report